# BALL Corp: overview

BALL · NYSE · CIK 9389 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ball.md) · [Financials](/companies/ball/financials.md) · [Filings](/companies/ball/filings.md) · [Insiders](/companies/ball/insiders.md)

Latest reported revenue: [$4.00bn](/filings/0001104659-26-090226.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001104659-26-090226).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,082](/filings/0001104659-25-106108.md) | [2,880](/filings/0001558370-25-001190.md) | [3,097](/filings/0001104659-26-055460.md) | [3,338](/filings/0001104659-26-090226.md) | [3,379](/filings/0001104659-25-106108.md) | [3,347 d](/filings/0001104659-26-017410.md) | [3,603](/filings/0001104659-26-055460.md) | [3,997](/filings/0001104659-26-090226.md) |
| Gross margin | % | [17.7%](/filings/0001558370-25-001190.md) | [16.7%](/filings/0001558370-25-001190.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [6.5%](/filings/0001104659-25-106108.md) | [(1.0%)](/filings/0001558370-25-001190.md) | [5.8%](/filings/0001104659-26-055460.md) | [6.4%](/filings/0001104659-26-090226.md) | [9.5%](/filings/0001104659-25-106108.md) | [6.0% d](/filings/0001104659-26-017410.md) | [5.7%](/filings/0001104659-26-055460.md) | [5.6%](/filings/0001104659-26-090226.md) |
| Diluted EPS | $ per share | [0.65](/filings/0001104659-25-106108.md) | [(0.11)](/filings/0001558370-25-001190.md) | [0.63](/filings/0001104659-26-055460.md) | [0.76](/filings/0001104659-26-090226.md) | [1.18](/filings/0001104659-25-106108.md) | not reported | [0.77](/filings/0001104659-26-055460.md) | [0.83](/filings/0001104659-26-090226.md) |
| Free cash flow | $m | [493 d](/filings/0001104659-25-106108.md) | [393 d](/filings/0001104659-26-017410.md) | [(746)](/filings/0001104659-26-055460.md) | [236 d](/filings/0001104659-26-090226.md) | [257 d](/filings/0001104659-25-106108.md) | [1,041 d](/filings/0001104659-26-017410.md) | [(938)](/filings/0001104659-26-055460.md) | [467 d](/filings/0001104659-26-090226.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.8](/filings/0001558370-24-001349.md) | [13.4](/filings/0001558370-25-001190.md) | [12.1](/filings/0001104659-26-017410.md) | [11.8](/filings/0001104659-26-017410.md) | [13.2](/filings/0001104659-26-017410.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.3%](/filings/0001558370-24-001349.md) | [9.1%](/filings/0001558370-24-001349.md) | [10.6%](/filings/0001558370-24-001349.md) | not reported | not reported |
| Net margin | % | [6.4%](/filings/0001558370-24-001349.md) | [5.5%](/filings/0001558370-25-001190.md) | [5.9%](/filings/0001104659-26-017410.md) | [34.0%](/filings/0001104659-26-017410.md) | [7.0%](/filings/0001104659-26-017410.md) |
| Diluted EPS | $ per share | [2.65](/filings/0001558370-24-001349.md) | [2.25](/filings/0001558370-25-001190.md) | [2.23](/filings/0001104659-26-017410.md) | [13.00](/filings/0001104659-26-017410.md) | [3.30](/filings/0001104659-26-017410.md) |
| Free cash flow | $bn | [0.0](/filings/0001558370-24-001349.md) | [(1.4)](/filings/0001558370-25-001190.md) | [0.8](/filings/0001104659-26-017410.md) | [(0.4)](/filings/0001104659-26-017410.md) | [0.8](/filings/0001104659-26-017410.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ball/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.31bn | 21,009,466 |  | Reduced −1,856,684 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.09bn | 17,422,457 |  | Added +46,950 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $837.2m | 13,416,598 |  | Added +1,024,861 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $718.6m | 11,515,810 |  | Reduced −59,758 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $547.8m | 8,779,385 |  | Added +4,234,072 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $460.4m | 7,411,580 |  | Added +155,203 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $441.1m | 7,096,160 |  | Reduced −10,387 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $429.9m | 6,889,505 |  | Reduced −221,476 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $406.7m | 6,517,214 |  | Added +517,805 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $401.5m | 6,434,199 |  | Added +2,451,576 |

## Recent filings

[All 3,163 filings](/companies/ball/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:41 ET | [8-K](/filings/0001104659-26-116918.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-116918 |
| 2026-09-09 | 12:09 ET | [8-K](/filings/0001104659-26-106140.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-106140 |
| 2026-08-04 | 17:08 ET | [10-Q](/filings/0001104659-26-090226.md) | Quarterly report, period 2026-06-30 | 0001104659-26-090226 |
| 2026-08-04 | 11:43 ET | [8-K](/filings/0001104659-26-090074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090074 |
| 2026-05-05 | 17:11 ET | [10-Q](/filings/0001104659-26-055460.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055460 |
| 2026-05-05 | 12:13 ET | [8-K](/filings/0000009389-26-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000009389-26-000107 |
| 2026-04-29 | 20:33 ET | [8-K](/filings/0000009389-26-000075.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000009389-26-000075 |
| 2026-03-17 | 20:22 ET | [DEF 14A](/filings/0001104659-26-029499.md) | Proxy statement, period 2026-04-29 | 0001104659-26-029499 |
| 2026-02-19 | 17:04 ET | [10-K](/filings/0001104659-26-017410.md) | Annual report, period 2025-12-31 | 0001104659-26-017410 |
| 2026-02-03 | 13:05 ET | [8-K](/filings/0000009389-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000009389-26-000039 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-017410.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/590f8e51-d191-4f35-b1d1-ef61e625e9e5)

## About the filer

- CIK: 9389
- Tickers: BALL
- Exchange: NYSE
- SIC code: 3411 Metal Cans
- State of incorporation: IN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.